Search Results

advanced fluorescent probes developed specifically for working with endogenous GLP-1R and GIPR across a range Available across multiple spectral ranges for confocal, super-resolution, and intravital imaging. daLUXendin

. << Back to podcast list Strategic Partner(s) Hacking GPCRs: Tools, Tech & Drug Discovery with Tom Sakmar I want to take it forward.” – Ilana Kotliar Dr. The Shift Toward Technology-Driven Biology “Today’s students want to multiplex, miniaturize, and engineer

<< Back to podcast list Strategic Partner(s) A Brief History of allosteric modulation with Dr.

. << Back to podcast list Strategic Partner(s) Maria Waldhoer: Pharmacological Fingerprints and the Limits

. << Back to podcast list Strategic Partner(s) Jennifer Pluznick: Olfactory Receptors in the Kidney and

. << Back to podcast list Strategic Partner(s) Amynah Pradhan: The Delta Opioid Receptor and the Migraine how a headache neurologist redirected two decades of work Key Insights from the Conversation The yin-yang to the receptor — tolerance, internalization, downregulation 14:17 Designing the delta agonist she wants

. << Back to podcast list Strategic Partner(s) Smells Like GPCR Spirit: Cracking Olfactory Codes with

<< Back to podcast list Strategic Partner(s) Self-Learning, Collaboration, and Delegation in Science

. << Back to podcast list Strategic Partner(s) Paul Insel: Rethinking COVID-19 Pathobiology Through GPCR It's what he would want a physician to understand if he were the one in the hospital bed. Conversation The angiotensin imbalance hypothesis of COVID-19 pathobiology — AT1R overdrive versus ACE2/Ang I really want to do something to help people. That's what this is all about, really." — Dr.

. << Back to podcast list Strategic Partner(s) Aaron Sato: Synthetic Antibody Libraries for the Hardest

<< Back to podcast list Strategic Partner(s) Dr. Aurélien Rizk About Dr. Aurélien Rizk "Dr.

. << Back to podcast list Strategic Partner(s) Silvio Gutkind: When GPCRs Drive Cancer GPCRs are the

. << Back to podcast list Strategic Partner(s) Terry Hébert This resilience conversation with Dr.

. << Back to podcast list Strategic Partner(s) Foord: Serendipity, RAMPs, And Industrial GPCR Pharmacology

. << Back to podcast list Strategic Partner(s) Fiona Marshall: Three Decades Inside GPCR Drug Discovery

. << Back to podcast list Strategic Partner(s) Beatriz Blanco-Redondo: Adhesion GPCR Discovery in Drosophila "When I moved back from the US, I was not sure I wanted to continue in science. "You come from disease and then you're working on a receptor and you want to study what happens there

. << Back to podcast list Strategic Partner(s) Antonella Di Pizio: Computational Pharmacology of Taste

intracellular receptor targeting are reshaping drug discover << Back to podcast list Strategic Partner(s) Terry Hébert wanted to be a microbiologist.

<< Back to podcast list Strategic Partner(s) Dr. Arthur Christopoulos About Dr.

. << Back to podcast list Strategic Partner(s) Jacob Lee and Jin Cho: Rebuilding the Software Layer Under Cho and Lee describe designing for the reality of shared benchwork: most labs want everything visible

<< Back to podcast list Strategic Partner(s) Dr. John Janetzko About Dr.

<< Back to podcast list Strategic Partner(s) Dr. Arthur Christopoulos About Dr.

. << Back to podcast list Strategic Partner(s) Arun Shukla: How Two Arrestins Regulate 800 GPCRs The "I was not, to be honest, sure if research was what I wanted to take up as a career. That is where I realized research is what I want to do for the rest of my life." "Initially we thought — I personally thought — that this is not what we want. But then later we realized in the lab that even if it is not what we want, it can be used for other things

. << Back to podcast list Strategic Partner(s) Ross Cheloha: Nanobody-GPCR Conjugates and the Engineering

. << Back to podcast list Strategic Partner(s) Brian Arey - Part 2: GPCR Drug Discovery and the Science This episode is for scientists who want to understand what early drug discovery actually costs - and

. << Back to podcast list Strategic Partner(s) Kathryn Livingston: Allosteric Opioid Modulators and Receptor

. << Back to podcast list Strategic Partner(s) Pfleger: NanoBRET, Receptor Complexes, and the Translation

. << Back to podcast list Strategic Partner(s) Paul Insel: Unbiased Discovery and the GPCRs We've Been

. << Back to podcast list Strategic Partner(s) Sam Hoare: Receptor Residence Time and GPCR Data Analysis

. << Back to podcast list Strategic Partner(s) Dr. Graduate student David Duran wanted to test intermittent fasting in mice. Dr. And when the brain wins, the antinociception is blocked — which is not what you want."